AzTrials
AzTrials

LeiomyomaTAPNCT04172272

The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures

A study testing Systemic multimodal analgesia administered intravenously, Transversus abdominis plane block (TAP block) and Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenously in people with Leiomyoma and Pelvic Organ Prolapse, run by General Hospital Pula at 2 sites in Croatia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates the influence of the transversus abdominis plane block on the intensity of postoperative pain and the concentration of proinflammatory and pain factors after hysterectomy by laparotomy. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Systemic multimodal analgesia administered intravenously, Transversus abdominis plane block (TAP block) and Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenously
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
2 sitesCroatia
Study dates
24 Sep 2019to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with a benign gynecological condition, who underwent hysterectomy by laparotomy approach.

Who cannot join

  • under aged
  • pregnant women,
  • patients with malignant gynecological disease,
  • those with anesthesiologic risk of ASA III or more,
  • persons who are hypersensitive to anesthetics and analgesics,
  • patients who do not agree with the study

Trial locations and contacts

2 sites in 1 country.

Dean Markić, MD, PHD, Prof. contact

+385915027956

dean.markic@medri.uniri.hr

Ivana Miletović, MD contact

385917818584

imiletovic@yahoo.com

Croatia2 sites, 2 recruiting
  • GH Pula

    Pula, 52100

    Irena Hrstić, MD,PHD, Assoc. Prof., +38552376400, irena.hrstic@obpula.hr

    Recruiting
  • Clinical centre Rijeka

    Rijeka, 51000

    Herman Haller, PHD, MD, prof., +38551658203, ginekologija@kbc-rijeka.hr

    Ines Krištofić, MD, +385915805283, ines.kristofic@gmail.com

    Recruiting

Other trials in Croatia

About this study

Official title: The Influence of the Transversus Abdominis Plane Block on the Intensity of Postoperative Pain and the Concentration of Proinflammatory and Pain Factors After Laparotomy for Gynecological Procedures

This study evaluates the influence of the transversus abdominis plane block on the intensity of postoperative pain and the concentration of proinflammatory and pain factors after hysterectomy by laparotomy. The patients will be randomized in three groups.In the first group, patients will receive intravenous, systemic, multimodal analgesia.In the second group there will be patients in who will be given the TAP block. The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block). In the third group there will be patients who will be treated with TAP block in addition to systemic, mutimodal analgesia. The research will be based on completing a questionnaire (VAS scale and QoR questionnaire) and taking peripheral blood out. We expect that the concentration of proinflammatory and pain factors in patients treated with a TAP block will be lower and the quality of recovery will be better than that of patients receiving standard analgesic therapy (systemic multimodal analgesia).

Read the detailed description

The influence of the transversus abdominis plane block on the intensity of postoperative pain and the concentration of proinflammatory and pain factors after laparotomy for gynecological procedures

Showing the problem

Hysterectomy is one of the most commonly performed surgical operations. Indications for hysterectomy are numerous and include benign and malignant etiology. Symptomatic leiomyomas, pelvic organ prolapse, abnormal uterine bleeding, endometriosis, chronic pain, and premalignant lesions are the most commonly benign indications for hysterectomy. The uterus can be removed using an abdominal, vaginal or laparoscopic approach. Each of these approaches is related to postoperative pain as well as on an increase in inflammatory factors that may adversely affect the recovery of patients. Therefore, pain management has become one of the major quality of life issues in the postoperative period. Post-operative pain is not only a limitation for the patient but the long-term pain can have deleterious effects on respiratory, cardiocirculatory and neuroendocrine function. Adverse physiological changes due to inadequate or insufficient postoperative analgesia can lead to increased morbidity and mortality to the patients.

The main assumption of the so-called "preventive analgesia" is to try to prevent the influx of nociceptive stimuli (surgical trauma) to the spinal cord and thus reduce postoperative pain. For this purpose, various anesthesiologic regional techniques (epidural analgesia, transversus abdominis plane block) are used for trying to reduce the activation of postoperative pain. Timely application of "preventive analgesia" and its long enough and intense action are essential as they could be captured all afferent nociceptive impulses. In the choice of optimal analgesia, the type and location of the procedure, the duration of the analgesic therapy required, individual risk factors and contraindications are of great importance. Preventive analgesia may be initiated immediately before the onset of tissue injury (eg epidural or spinal analgesia), immediately after surgery using regional blocks or intravenous analgesia for a well-defined period of time (eg at intervals of 3 to 6 hours). The goal of quality treatment of acute pain is not only optimal analgesia, but also for reducing complications. One of the newer techniques for postoperative analgesia is a transversus abdominis plane block (TAP), which is part of regional anesthesia techniques. It is a peripheral nerve block that blocks nerves located in the fascia layer between the m. transversus abdominis and the m. obliqus internus, which innervate the anterolateral abdominal wall. These nerves include the intercostal (Th7-Th11), subcostal (Th12), iliohypogastric and ilioinguinal (L1) nerves. A local anesthetic administered in the layer between the m. transversus abdominis and the m. obliqus internus results in anesthesia of the anterolateral abdominal wall. This technique achieves analgesia of the skin, subcutaneous, muscle, and parietal peritoneum in a given region. The blockage of these nerves is useful primarily for postoperative analgesia after abdominal surgery, including gynecologal too.

In major surgical procedures such as uterine removal (hysterectomy), pain and stress caused by surgical tissue injury stimulate a strong pro-inflammatory response, so establishing effective postoperative analgesia which adequately relieved the pain is of great importance. In this study, investigators will evaluate the effect of a transversus abdominis plane block on the severity of postoperative pain as well as its effect on proinflammatory and pain factors in patients following gynecologic surgery performed with a laparotomy approach. The investigators will also compare the use of standard systemic multimodal analgesia and the TAP block (as well as their combination) in the control of postoperative pain. Studies have shown that both approaches are effective in controlling postoperative pain, but comparative studies are rare, and none has so far examined the concentration of proinflammatory and pain factors in operated patients.

Hypothesis

The basic hypothesis is that a transversus abdominis plane block reduces postoperative pain in patients after gynecologic surgery performed with a laparotomic approach. The expectation is that the concentration of proinflammatory and pain factors in patients treated with a TAP block will be lower and the quality of recovery will be better than that of patients receiving standard analgesic therapy (systemic multimodal analgesia).

Objectives of the research

  1. Compare the three forms of postoperative analgesia dividing patients in the three groups (TAP block only, systemic multimodal analgesia only and combined TAP block with systemic multimodal analgesia) after gynecological surgeries to show which one has the highest value in controlling postoperative pain.
  2. Analyze the impact of the TAP block on postoperative pain, using a visual analogue scale (VAS) in patients after gynecological surgery.
  3. Analyze the impact of TAP block combined with systemic, multimodal analgesia on postoperative pain, using the VAS scale, in patients after gynecological surgery.
  4. Analyze the concentration of proinflammatory cytokines and pain factors (IL-1ß, IL-6, cortisol, catecholamines) in the plasma of patients who will receive a TAP block after gynecological surgery.
  5. Analyze the impact of the TAP block on the quality of recovery, measured with quality of recovery (QoR) questionnaire in patients after gynecological surgery.
  6. Correlate values of subjective assessment of postoperative pain intensity using VAS scale with concentration of proinflammatory and biomarkers for pain (IL-1ß, IL-6, cortisol, catecholamines) in patients in whom postoperative pain after gynecological surgery will be treated with TAP block or systemic multimodal analgesia.

Construction of the study

The structure will be a prospective, randomized, single-blind study.

Subjects (Material)

The number of women enrolled in the study will be 75. Patients will be interviewed in detail prior to surgery to be informed of planned anesthesia, surgery and postoperative pain control, and will sign informed consent and consent to participate in the study.

From each patient by standard technique venous blood will be taken out from peripheral vein at certain intervals after surgery. The patients will be asked by the examiner to complete VAS scale or and the QoR questionnaire.

Methods

Hysterectomy and / or adnexectomy will be performed in patients included in the study due to benign gynecological pathology with a laparotomy approach. Baseline patient data will be determined based on a detailed medical history and medical records, clinical examination of each patient and imaging tests. A definitive diagnosis of benign gynecological pathology will be obtained after a histopathological analysis of the tissue. A detailed interview will be done with the patients before surgery, and patients will be informed about the planned anesthesia, surgery and postoperative pain control. After that patients will sign an informed consent and the consent for participating in the study. For the purpose of the study, patients will be randomized into three groups regarding to the treatment technique for postoperative pain. The doctor ( researcher) will, by the computer program Datlnf Ranolist do the randomization. So that way the researcher will determine the type of analgesia the patient will receive. In the first group, patients will receive intravenous, systemic, multimodal analgesia: paracetamol 1 gram and ketoprofen 100 mg every 8 hours for 24 hours. Analgesia will start immediately after surgery. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed. In the second group there will be patients in who will be given the TAP block. The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block) of 0.25% levobupivacin in 40 ml bilaterally. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient. In the third group there will be patients who will be treated with TAP block in addition to systemic, mutimodal analgesia. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient. The standardized protocol will determine the general information of each patient to be included in the study: ID, age and gender. 25 patients will be included in each group. The research will be based on completing a questionnaire (VAS scale and QoR questionnaire) and taking peripheral blood out. Blood will be taken from the peripheral vein by standard technique in a volume of 10 ml before surgery and 6, 24 and 48 hours after surgery. VAS scale (at rest and in motion) will be determined before surgery and 3, 6, 12, 24 and 48 hours after surgery. The QoR questionnaire will be examined before surgery, 24 hours after surgery and 30 days after surgery. The concentrations of individual cytokines (IL-1ß, IL-6) and hormones (catecholamines, cortisol) related to inflammation and pain will be determined by standard laboratory methods from peripheral blood. Cytokine and hormone concentrations will be determined by enzyme immunofluorescence method according to the manufacturer's instructions. All results obtained through the questionnaire or blood test will only serve for the purpose of the study and will not have diagnostic, therapeutic or prognostic value for the patients included in the study.

Statistical methods

Statistical data processing will be performed in the Statistica 12.0 computer program (StatSoft, Inc., Tulsa, OK, USA). When calculating differences between experimental groups, investigators will use the Kruskal Walis ANOVA nonparametric test for small independent samples. Changes will be considered statistically significant with p <0.05. We will use the Mann-Whitney U test subsequently to determine between which two of the more comparable groups there is statistical significance. Correlations will be examined by Pearson or Spearman correlation test, depending on the results of the data distribution analysis. Differences between variables expressed at nominal level will be examined using the chi-square test. Image and spreadsheet views of the results will be made in Microsoft Excel and Statistica 12.0.

Expected scientific contribution

It is hoped that the results of the proposed study will shed light on the impact of various anesthesiologic techniques (transversus abdominis plane block, intravenous systemic multimodal analgesia and their combination) on postoperative pain and the concentration of proinflammatory and pain factors after gynecologic surgery performed with a laparotomy approach. Investigators expect that the use of regional analgesia technique (TAP block) will lead to a reduction in postoperative pain and proinflammatory factors and pain factors examined, thereby contributing to a faster recovery and better outcome of their treatment.

Being tested
Systemic multimodal analgesia administered intravenously, Transversus abdominis plane block (TAP block), Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenously
Keywords
Transversus abdominis plane block, Laparotomy, Hysterectomy, Postoperative pain, Cytokines, Visual analogue scale, Quality of recovery
Medical subject headings
Leiomyoma, Pelvic Organ Prolapse, Metrorrhagia, Chronic Pain, Endometriosis, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Systemic multimodal analgesia administered intravenouslyDrug

    Paracetamol 1 gram and ketoprofen 100 mg every 8 hours for 24 hours. Analgesia will start immediately after surgery. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.

  • Transversus abdominis plane block (TAP block)Procedure or surgery

    The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block) of 0.25% levobupivacin in 40 ml bilaterally. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.

  • Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenouslyOther

    TAP block in addition to systemic, mutimodal analgesia. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient.

Study groups in NCT04172272
Study groupRoleWhat they receive
Systemic multimodal analgesia onlyActive comparatorIn the first group, patients will receive intravenous, systemic, multimodal analgesia: paracetamol 1 gram and ketoprofen 100 mg every 8 hours for 24 hours. Analgesia will start immediately after surgery. If the pain persists, the patient will be given "rescue" analgesia: tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.
Receives: Drug: Systemic multimodal analgesia administered intravenously
TAP block onlyExperimentalIn the second group there will be patients in who will be given the TAP block. The TAP block will be given postoperatively before waking. It will be given bilaterally in the before mentioned anatomic region (the so-called lateral TAP block) of 0.25% levobupivacaine in 40 ml bilaterally. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient.
Receives: Procedure: Transversus abdominis plane block (TAP block)
Combined TAP block with systemic multimodal analgesiaExperimentalIn the third group there will be patients who will be treated with TAP block in addition to systemic, mutimodal analgesia. If such analgesia is not satisfactory, tramadol 50 mg intravenously, up to a maximum dose of 400 mg / 24h, and other analgesics will be given at the request of the patient.
Receives: Other: Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenously

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The impact of three forms of postoperative analgesia (TAP block, systemic multimodal analgesia, combined TAP block and systemic multimodal analgesia)on postoperative pain after gynecological surgery

    Self-reported pain intensity using a standard visual analogue scale (VAS, from 0 to 10) in patients after gynecological surgery.

    Measured: 48 hours

  2. Concentration of proinflammatory and pain factors in patients on postoperative pain after gynecological surgery

    Change in concentrations of individual cytokines (IL-1ß, IL-6) and hormones (catecholamines, cortisol) related to inflammation and pain

    Measured: Before surgery and 6, 24 and 48 hours after surgery

  3. Quality of recovery after gynecological surgery

    The impact of three forms of postoperative analgesia (TAP block, systemic multimodal analgesia and combined TAP block and systemic multimodal analgesia) on the quality of recovery in patients after gynecological surgery, measured by using a widely accepted 40-item Quality of Recovery (QoR) questionnaire

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2019
  2. Study start24 Sep 2019
  3. Primary completion24 Sep 2020 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04172272
Sponsor's protocol ID
3
Acronym
TAP
Status last verified
Nov 2019
First submitted
8 Nov 2019
Last updated
21 Nov 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Young MJ, Gorlin AW, Modest VE, Quraishi SA. Clinical implications of the transversus abdominis plane block in adults. Anesthesiol Res Pract. 2012;2012:731645. doi: 10.1155/2012/731645. Epub 2012 Jan 19.

    PubMed 22312327
  • McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f.

    PubMed 17179269
  • Abdallah FW, Chan VW, Brull R. Transversus abdominis plane block: a systematic review. Reg Anesth Pain Med. 2012 Mar-Apr;37(2):193-209. doi: 10.1097/AAP.0b013e3182429531.

    PubMed 22286518
  • Yoshida T, Furutani K, Watanabe Y, Ohashi N, Baba H. Analgesic efficacy of bilateral continuous transversus abdominis plane blocks using an oblique subcostal approach in patients undergoing laparotomy for gynaecological cancer: a prospective, randomized, triple-blind, placebo-controlled study. Br J Anaesth. 2016 Dec;117(6):812-820. doi: 10.1093/bja/aew339.

    PubMed 27956680
  • Dai C, Zhang K, Huang J. The Efficacy of Transversus Abdominis Plane Block for Abdominal Hysterectomy Post-operative Analgesia. Cureus. 2018 Aug 10;10(8):e3131. doi: 10.7759/cureus.3131.

    PubMed 30345190
  • Easterday CL, Grimes DA, Riggs JA. Hysterectomy in the United States. Obstet Gynecol. 1983 Aug;62(2):203-12.

    PubMed 6408544
  • American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012 Feb;116(2):248-73. doi: 10.1097/ALN.0b013e31823c1030. No abstract available.

    PubMed 22227789
  • Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008.

    PubMed 26827847

Questions about this trial

What is this clinical trial studying?

A study testing Systemic multimodal analgesia administered intravenously, Transversus abdominis plane block (TAP block) and Combined transversus abdominis plane block (TAP block) with systemic multimodal analgesia administered intravenously in people with Leiomyoma and Pelvic Organ Prolapse, run by General Hospital Pula at 2 sites in Croatia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dean Markić, MD, PHD, Prof. (+385915027956, dean.markic@medri.uniri.hr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The impact of three forms of postoperative analgesia (TAP block, systemic multimodal analgesia, combined TAP block and systemic multimodal analgesia)on postoperative pain after gynecological surgery (time frame: 48 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04172272, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in